Brief: Lyra Therapeutics Announces Completion Of Enrollment In Phase 2 Clinical Trial Of LYR-220 In Post-Surgical Rhinosinusitis Patients
06/02/2023 17:07
Feb 6 (Reuters) - Lyra Therapeutics Inc LYRA.O :
* LYRA THERAPEUTICS ANNOUNCES COMPLETION OF ENROLLMENT IN
THE
BEACON PHASE 2 CLINICAL TRIAL OF LYR-220 IN POST-SURGICAL
CHRONIC RHINOSINUSITIS PATIENTS
* LYRA THERAPEUTICS INC - TOPLINE RESULTS ARE EXPECTED IN Q4
OF
2023
Source text for Eikon: ID:nGNX7czb46
Further company coverage: LYRA.O
((Reuters.Briefs@thomsonreuters.com;))